Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22646 | 318 | 52.9 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
151 | 22214 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RECOMBINANT VACCINE GRP | Address | 6 | 100% | 1% | 4 |
2 | ABSCOPAL EFFECT | Author keyword | 3 | 32% | 3% | 9 |
3 | IMMUNOGENIC TUMOR CELL DEATH | Author keyword | 2 | 67% | 1% | 2 |
4 | ABSCOPAL EFFECTS | Author keyword | 2 | 43% | 1% | 3 |
5 | ACUTE PHASE INFLAMMATION | Author keyword | 1 | 50% | 0% | 1 |
6 | ANTI CD25 THERAPY | Author keyword | 1 | 50% | 0% | 1 |
7 | BIOPHYS UNIT IBILI | Address | 1 | 50% | 0% | 1 |
8 | CELLULAR IMMUNE RADIOBIOL | Address | 1 | 50% | 0% | 1 |
9 | CRCNA UMR 892 | Address | 1 | 50% | 0% | 1 |
10 | HYPO FRACTIONATED RADIOTHERAPY | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABSCOPAL EFFECT | 3 | 32% | 3% | 9 | Search ABSCOPAL+EFFECT | Search ABSCOPAL+EFFECT |
2 | IMMUNOGENIC TUMOR CELL DEATH | 2 | 67% | 1% | 2 | Search IMMUNOGENIC+TUMOR+CELL+DEATH | Search IMMUNOGENIC+TUMOR+CELL+DEATH |
3 | ABSCOPAL EFFECTS | 2 | 43% | 1% | 3 | Search ABSCOPAL+EFFECTS | Search ABSCOPAL+EFFECTS |
4 | ACUTE PHASE INFLAMMATION | 1 | 50% | 0% | 1 | Search ACUTE+PHASE+INFLAMMATION | Search ACUTE+PHASE+INFLAMMATION |
5 | ANTI CD25 THERAPY | 1 | 50% | 0% | 1 | Search ANTI+CD25+THERAPY | Search ANTI+CD25+THERAPY |
6 | HYPO FRACTIONATED RADIOTHERAPY | 1 | 50% | 0% | 1 | Search HYPO+FRACTIONATED+RADIOTHERAPY | Search HYPO+FRACTIONATED+RADIOTHERAPY |
7 | ICD INDUCERS | 1 | 50% | 0% | 1 | Search ICD+INDUCERS | Search ICD+INDUCERS |
8 | IMMUNE EDITING | 1 | 50% | 0% | 1 | Search IMMUNE+EDITING | Search IMMUNE+EDITING |
9 | IMMUNO FLOW CYTOMETRY | 1 | 50% | 0% | 1 | Search IMMUNO+FLOW+CYTOMETRY | Search IMMUNO+FLOW+CYTOMETRY |
10 | LMP10 | 1 | 50% | 0% | 1 | Search LMP10 | Search LMP10 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LOCAL RADIATION | 24 | 68% | 7% | 21 |
2 | LOCAL TUMOR IRRADIATION | 12 | 86% | 2% | 6 |
3 | COMBINING RADIOTHERAPY | 5 | 63% | 2% | 5 |
4 | ANTITUMOR IMMUNOTHERAPY | 5 | 55% | 2% | 6 |
5 | LOCAL RADIATION THERAPY | 5 | 44% | 3% | 8 |
6 | ENHANCES TUMOR RESPONSE | 4 | 41% | 2% | 7 |
7 | ABSCOPAL | 3 | 60% | 1% | 3 |
8 | METASTATIC LUNG CANCER | 2 | 38% | 2% | 5 |
9 | ALPHA MEDIATED INDUCTION | 2 | 67% | 1% | 2 |
10 | IN SITU VACCINATION | 2 | 27% | 2% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Combining Immunotherapy and Radiation for Prostate Cancer | 2015 | 2 | 51 | 53% |
Antitumor immune responses induced by ionizing irradiation and further immune stimulation | 2014 | 15 | 36 | 33% |
The Effect of Radiation on the Immune Response to Cancers | 2014 | 8 | 59 | 51% |
The impact of radiation therapy on the antitumor immunity: Local effects and systemic consequences | 2015 | 3 | 139 | 28% |
Combinations of Radiation Therapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes | 2014 | 18 | 63 | 22% |
Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment | 2015 | 1 | 67 | 52% |
Abscopal effects of radiation therapy: A clinical review for the radiobiologist | 2015 | 4 | 89 | 19% |
Systemic effects of local radiotherapy | 2009 | 114 | 64 | 27% |
Combining radiation and immunotherapy for synergistic antitumor therapy | 2009 | 20 | 28 | 68% |
Radiation and immunotherapy: a synergistic combination | 2013 | 23 | 56 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RECOMBINANT VACCINE GRP | 6 | 100% | 1.3% | 4 |
2 | BIOPHYS UNIT IBILI | 1 | 50% | 0.3% | 1 |
3 | CELLULAR IMMUNE RADIOBIOL | 1 | 50% | 0.3% | 1 |
4 | CRCNA UMR 892 | 1 | 50% | 0.3% | 1 |
5 | ID SCI IT SERV | 1 | 50% | 0.3% | 1 |
6 | PUBL HLTH BIOSTAT RADIOL | 1 | 50% | 0.3% | 1 |
7 | ROYCE | 1 | 50% | 0.3% | 1 |
8 | UROLBARBARA ANN KARMANOS CANC | 1 | 50% | 0.3% | 1 |
9 | CANC SCITARGETED THER Y GRP | 0 | 33% | 0.3% | 1 |
10 | CANC UK MRC OXFORD RADIAT ONCOL | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000209585 | FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL |
2 | 0.0000189863 | MED CLIN 9//SECT RECONSTRUCT PLAST SURG//BIOMED ENGN IMAGING |
3 | 0.0000172402 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
4 | 0.0000137454 | CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION |
5 | 0.0000127952 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
6 | 0.0000125860 | HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP |
7 | 0.0000103679 | BOVINE BETALACTOGLOBULIN//MUCOSAL ANTIGENS//BR AMBEDKAR ROTARY CANC HOSP |
8 | 0.0000096653 | CTLA 4//IPILIMUMAB//CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 |
9 | 0.0000091241 | ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE |
10 | 0.0000088589 | BELAGENPUMATUCEL L//SRL172//PA MSHA |